Draxxin
Loading...Draxxin Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
FOR USE IN ANIMALS ONLY.
NOT FOR HUMAN USE.
KEEP OUT OF REACH OF CHILDREN.
NOT FOR USE IN CHICKENS OR TURKEYS.
RESIDUE WARNINGS
Cattle
Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment. Do not use in female dairy cattle 20 months of age or older.
Swine
Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
DRAXXIN consists of an equilibrated mixture of two isomeric forms of tulathromycin in a 9:1 ratio. Structures of the isomers are shown below.
Figure 1.
The chemical names of the isomers are (2R,3S, 4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4-C-[(propylamino) methyl]-α-L-ribo-hexopyrano-syl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylohexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one and (2R, 3R,6R, 8R,9R,10S,11S,12R)-11-[[2,6-dideoxy-3-C-methyl- 3-Ο-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyrano-syl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylohexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one, respectively.
Sources
Draxxin Manufacturers
-
Zoetis Inc.
![Draxxin (Tulathromycin) Injection, Solution [Zoetis Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Draxxin | Zoetis Inc.
Cattle
Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight (BW). Do not inject more than 10 mL per injection site.
Table 1. DRAXXIN Cattle Dosing Guide Animal Weight
(Pounds) Dose Volume
(mL) 100 1.1 200 2.3 300 3.4 400 4.5 500 5.7 600 6.8 700 8.0 800 9.1 900 10.2 1000 11.4Swine
Inject intramuscularly as a single dose in the neck at a dosage of 2.5 mg/kg (0.25 mL/22 lb) BW. Do not inject more than 2.5 mL per injection site.
Table 2. DRAXXIN Swine Dosing Guide Animal Weight
(Pounds) Dose Volume
(mL) 15 0.2 30 0.3 50 0.6 70 0.8 90 1.0 110 1.3 130 1.5 150 1.7 170 1.9 190 2.2 210 2.4 230 2.6 250 2.8 270 3.1 290 3.3 -
Pfizer Animal Health
Draxxin | Pfizer Animal Health
CattleInject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight (BW). Do not inject more than 10 mL per injection site.
Table 1. DRAXXIN Cattle Dosing Guide Animal Weight
(Pounds) Dose Volume
(mL) 100 1.1 200 2.3 300 3.4 400 4.5 500 5.7 600 6.8 700 8.0 800 9.1 900 10.2 1000 11.4 SwineInject intramuscularly as a single dose in the neck at a dosage of 2.5 mg/kg (0.25 mL/22 lb) BW. Do not inject more than 2.5 mL per injection site.
Table 2. DRAXXIN Swine Dosing Guide Animal Weight
(Pounds) Dose Volume
(mL) 15 0.2 30 0.3 50 0.6 70 0.8 90 1.0 110 1.3 130 1.5 150 1.7 170 1.9 190 2.2 210 2.4 230 2.6 250 2.8 270 3.1 290 3.3
![Draxxin (Tulathromycin) Injection, Solution [Pfizer Animal Health]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ff7ef1a8-0c89-45af-8244-96b284bf7b1b&name=draxxin-03.jpg)
Login To Your Free Account